Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel Clanet

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
International MS Journal|January 19, 2006
Motivating MS patients: the Annual Convention 2005 of the MS Forum, 22 May 2005, St Julians, MaltaMichel Clanet
Journal International De Bioethique Et D'Ethique Des Sciences|October 9, 2023
Michel Clanet
International MS Journal|January 19, 2006
Therapeutic developments in MS: report from the 57th Annual Meeting of the American Academy of Neurology (AAN), 9-15 April 2004, Miami, Florida, USAMichel Clanet
Journal International De Bioethique Et D'Ethique Des Sciences|September 8, 2023
Michel Clanet
International MS Journal|January 20, 2006
MS treatment optimization: report from the 21st ETRIMS/10th ACTRIMS Congress, 28 September-1 October 2005, Thessaloniki, GreeceMichel Clanet, Reinhard Hohlfeld
Fundamental & Clinical Pharmacology|June 24, 2018
Cervical dysplasia in a patient with multiple sclerosis treated with natalizumabGeneviève Durrieu, Quentin Dardonville, Michel Clanet, et al.
AIDS (London, England)|April 20, 2004
Progressive multifocal leukoencephalopathy in an HIV patient with normal CD4 T-cell count and magnetic resonance imagingPierre Delobel, David Brassat, Marie B Delisle, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 10, 2018
Late-onset neutropenia and neurological relapse, during long-term rituximab therapy in myelin oligodendrocyte glycoprotein-antibody spectrum disorderDamien Biotti, Fleur Lerebours, Fabrice Bonneville, et al.
Journal of Neuroimmunology|December 11, 2007
Thymic output and peripheral T lymphocyte subsets in relapsing--remitting multiple sclerosis patients treated or not by IFN-betaBénédicte Puissant-Lubrano, Frédérique Viala, Peter Winterton, et al.
Magma (New York, N.Y.)|November 11, 2008
Relevance of the skewness index in DTI exploration of multiple sclerosisEliane Graulières, Jean-Albert Lotterie, Emmanuelle Cassol, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
International MS Journal|January 19, 2006
Motivating MS patients: the Annual Convention 2005 of the MS Forum, 22 May 2005, St Julians, MaltaMichel Clanet
Journal International De Bioethique Et D'Ethique Des Sciences|October 9, 2023
Michel Clanet
International MS Journal|January 19, 2006
Therapeutic developments in MS: report from the 57th Annual Meeting of the American Academy of Neurology (AAN), 9-15 April 2004, Miami, Florida, USAMichel Clanet
Journal International De Bioethique Et D'Ethique Des Sciences|September 8, 2023
Michel Clanet
International MS Journal|January 20, 2006
MS treatment optimization: report from the 21st ETRIMS/10th ACTRIMS Congress, 28 September-1 October 2005, Thessaloniki, GreeceMichel Clanet, Reinhard Hohlfeld
Fundamental & Clinical Pharmacology|June 24, 2018
Cervical dysplasia in a patient with multiple sclerosis treated with natalizumabGeneviève Durrieu, Quentin Dardonville, Michel Clanet, et al.
AIDS (London, England)|April 20, 2004
Progressive multifocal leukoencephalopathy in an HIV patient with normal CD4 T-cell count and magnetic resonance imagingPierre Delobel, David Brassat, Marie B Delisle, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 10, 2018
Late-onset neutropenia and neurological relapse, during long-term rituximab therapy in myelin oligodendrocyte glycoprotein-antibody spectrum disorderDamien Biotti, Fleur Lerebours, Fabrice Bonneville, et al.
Journal of Neuroimmunology|December 11, 2007
Thymic output and peripheral T lymphocyte subsets in relapsing--remitting multiple sclerosis patients treated or not by IFN-betaBénédicte Puissant-Lubrano, Frédérique Viala, Peter Winterton, et al.
Magma (New York, N.Y.)|November 11, 2008
Relevance of the skewness index in DTI exploration of multiple sclerosisEliane Graulières, Jean-Albert Lotterie, Emmanuelle Cassol, et al.
Pageof 5